#Other Patient ID	Patient Identifier	Form completion date	Tissue Prospective Collection Indicator	Tissue Retrospective Collection Indicator	Sex	Race Category	Ethnicity Category	Prior Cancer Diagnosis Occurence	Neoadjuvant Therapy Type Administered Prior To Resection Text	Person Neoplasm Status	Did patient start adjuvant postoperative radiotherapy?	Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator	Mitotane Therapy	Mitotane Therapy adjuvant setting	Therapeutic Mitotane levels achieved	Therapeutic Mitotane lvl recurrence	Mitotane Therapy for macroscopic residual disease	Therapeutic Mitotane lvl macroscopic residual	Therapeutic Mitotane lvl progression	Clinical Status Within 3 Mths Surgery	Primary Therapy Outcome Success Type	Primary Tumor Laterality	Neoplasm Histologic Type Name	Year Cancer Initial Diagnosis	Ct scan preop results	Primary Lymph Node Presentation Assessment Ind-3	Lymph Node(s) Examined Number	Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count	Weiss Score Overall	Mitoses Count	Neoplasm Disease Stage American Joint Committee on Cancer Code	Surgical Margin Resection Status	Metastatic Neoplasm Confirmed Diagnosis Method Name	Metastatic Neoplasm Confirmed Diagnosis Method Text	Patient Metastatic Sites	Excess Adrenal Hormone History Type	Excess Adrenal Hormone Diagnosis Method Type	Molecular Analysis Performed Indicator	New Neoplasm Event Post Initial Therapy Indicator	Diagnosis Age	Atypical Mitotic Figures	Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage	Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage	Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage	Neoplasm American Joint Committee on Cancer Clinical Group Stage	Cytoplasm Presence Less Than Equal 25 Percent	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Last Communication Contact from Initial Pathologic Diagnosis Date	Diffuse Architecture	Disease code	Lymphomatous Extranodal Site Involvement Indicator	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	Informed consent verified	CAPSULAR INVASION	Mitotic Rate	Necrosis	Nuclear Grade III IV	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Project code	RET	SDHA	SDHAF2 SDH5	SDHB	SDHC	SDHD	Sinusoid Invasion	Stage Other	American Joint Committee on Cancer Publication Version Type	Tissue Source Site	Tmem127	Tumor Tissue Site	Von Hippel-Lindau	Weiss Venous Invasion	Overall Survival Status	Overall Survival (Months)	Disease Free Status	Disease Free (Months)
#Legacy DMP patient identifier (DMPnnnn)	Identifier to uniquely specify a patient.	Form completion date	Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.	Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.	Sex	The text for reporting information about race.	The text for reporting information about ethnicity.	Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.	Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.	The state or condition of an individual's neoplasm at a particular point in time.	A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.	Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.	Mitotane Therapy	Mitotane Therapy Adjuvant Setting	Therapeutic Mitotane Levels Achieved	Therapeutic Mitotane Lvl Recurrence	Mitotane Therapy For Macroscopic Residual Disease	Therapeutic Mitotane Lvl Macroscopic Residual	Therapeutic Mitotane Lvl Progression	Clinical Status Within 3 Mths Surgery	Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).	For tumors in paired organs, designates the side on which the cancer originates.	Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.	Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.	Diagnostic ct result outcome	the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.	The total number of lymph nodes removed and pathologically assessed for disease.	Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.	Weiss Score Overall	Mitoses Count	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	Text terms to describe the status of a tissue margin following surgical resection.	Metastatic Neoplasm Confirmed Diagnosis Method Name	Metastatic Neoplasm Confirmed Diagnosis Method Text	The anatomic location to which the cancer has spread.	Excess Adrenal Hormone History Type	Excess Adrenal Hormone Diagnosis Method Type	Molecular Analysis Performed Indicator	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	Age at which a condition or disease was first diagnosed.	Atypical Mitotic Figures	Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.	Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.	Cytoplasm Presence Less Than Equal 25 Percent	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..	Diffuse Architecture	Disease code	Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	Informed consent verified	CAPSULAR INVASION	Mitotic Rate	Necrosis	Nuclear Grade III IV	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Project code	RET	SDHA	SDHAF2 SDH5	SDHB	SDHC	SDHD	Sinusoid Invasion	Stage Other	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.	Tmem127	Text term that describes the anatomic site of the tumor or disease.	Von Hippel-Lindau syndrome (VHL) is a hereditary condition associated with hemangioblastomas, which are blood vessel tumors of the brain, spinal cord, and eye.	Weiss Venous Invasion	Overall patient survival status.	Overall survival in months since initial diagonosis.	Disease free status since initial diagnosis.	Disease free (months) since initial diagnosis.
#STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	NUMBER	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	NUMBER
#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
OTHER_PATIENT_ID	PATIENT_ID	FORM_COMPLETION_DATE	PROSPECTIVE_COLLECTION	RETROSPECTIVE_COLLECTION	SEX	RACE	ETHNICITY	HISTORY_OTHER_MALIGNANCY	HISTORY_NEOADJUVANT_TRTYN	TUMOR_STATUS	RADIATION_TREATMENT_ADJUVANT	PHARMACEUTICAL_TX_ADJUVANT	PHARM_TX_MITOTANE_INDICATOR	PHARM_TX_MITOTANE_ADJUVANT	PHARM_TX_MITOTANE_THERAPUTIC_LEVELS	PHARM_TX_MITOTANE_THERAPUTIC_AT_REC	PHARM_TX_MITOTANE_FOR_MACRO_DISEASE	PHARM_TX_MITOTANE_THERAPUTIC_MACRO	PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG	CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY	TREATMENT_OUTCOME_FIRST_COURSE	LATERALITY	HISTOLOGICAL_DIAGNOSIS	INITIAL_PATHOLOGIC_DX_YEAR	CT_SCAN_PREOP_RESULTS	LYMPH_NODES_EXAMINED	LYMPH_NODE_EXAMINED_COUNT	LYMPH_NODES_EXAMINED_HE_COUNT	WEISS_SCORE_OVERALL	MITOSES_PER_50_HPF	AJCC_PATHOLOGIC_TUMOR_STAGE	RESIDUAL_TUMOR	METASTATIC_DX_CONFIRMED_BY	METASTATIC_DX_CONFIRMED_BY_OTHER	METASTATIC_SITE_PATIENT	HISTORY_ADRENAL_HORMONE_EXCESS	HISTORY_BASIS_ADRENAL_HORMONE_DX	MOLECULAR_STUDIES_OTHERS_PERFORMED	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	AGE	ATYPICAL_MITOTIC_FIGURES	CLIN_M_STAGE	CLIN_N_STAGE	CLIN_T_STAGE	CLINICAL_STAGE	CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	DAYS_LAST_FOLLOWUP	DIFFUSE_ARCHITECTURE	DISEASE_CODE	EXTRANODAL_INVOLVEMENT	ICD_10	ICD_O_3_HISTOLOGY	ICD_O_3_SITE	INFORMED_CONSENT_VERIFIED	CAPSULAR_INVASION	MITOTIC_RATE	NECROSIS	NUCLEAR_GRADE_III_IV	PATH_M_STAGE	PATH_N_STAGE	PATH_T_STAGE	PROJECT_CODE	RET	SDHA	SDHAF2_SDH5	SDHB	SDHC	SDHD	SINUSOID_INVASION	STAGE_OTHER	AJCC_STAGING_EDITION	TISSUE_SOURCE_SITE	TMEM127	SITE_OF_TUMOR_TISSUE	VHL	WEISS_VENOUS_INVASION	OS_STATUS	OS_MONTHS	DFS_STATUS	DFS_MONTHS
B3164F7B-C826-4E08-9EE6-8FF96D29B913	TCGA-OR-A5J1	2014-4-2	NO	YES	Male	WHITE	[Not Evaluated]	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2000	[Unknown]	[Unknown]	[Not Available]	[Not Available]	3	5	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Mineralocorticoids	[Unknown]	NO	YES	58	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/1	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	44.51	1:Recurred/Progressed	24.77
8E7C2E31-D085-4B75-A970-162526DD07A0	TCGA-OR-A5J2	12/3/13	NO	YES	Female	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2004	YES	YES	1	0	8	0	Stage IV	R2	Imaging Suspected	[Not Available]	Lung	Androgen	Both Clinical and Biochemical Assessments	NO	YES	44	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	55.09	1:Recurred/Progressed	9.49
DFD687BC-6E69-42F7-AF94-D17FC150D1A1	TCGA-OR-A5J3	12/2/13	NO	YES	Female	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2008	YES	YES	4	0	6	6	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	YES	YES	23	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1942	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	68.69	1:Recurred/Progressed	37.75
5F3E2974-F1DF-47A2-8A8A-29BB525EEEF6	TCGA-OR-A5J4	12/2/13	NO	YES	Female	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2000	YES	YES	2	2	6	77	Stage IV	R2	Imaging Suspected	[Not Available]	Lung	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	23	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	13.9	1:Recurred/Progressed	4.14
802DBD0D-EF07-4C91-AB8D-1DD39532E947	TCGA-OR-A5J5	12/3/13	NO	YES	Male	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	[Not Available]	[Not Available]	Persistent locoregional disease	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2000	YES	NO	[Not Available]	[Not Available]	6	3	Stage III	R2	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	YES	30	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	11.99	1:Recurred/Progressed	1.64
C8898B42-B704-45A0-9829-144B98F416E0	TCGA-OR-A5J6	12/3/13	NO	YES	Female	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2006	YES	NO	[Not Available]	[Not Available]	3	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	YES	NO	29	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2428	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	88.8	0:DiseaseFree	88.80
075DBFD0-9CF4-4877-884F-AE858902C79E	TCGA-OR-A5J7	12/2/13	NO	YES	Female	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2009	YES	YES	1	0	6	3	Stage III	R1	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	YES	YES	30	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	16.1	1:Recurred/Progressed	5.32
08E0D412-D4D8-4D13-B792-A4DD0BD9EC2B	TCGA-OR-A5J8	12/3/13	NO	YES	Male	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	YES	YES	YES	YES	NO	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	1	0	8	15	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	YES	YES	66	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	19.02	1:Recurred/Progressed	17.41
A53E9117-0A49-40D8-AF40-7867370B671A	TCGA-OR-A5J9	12/3/13	NO	YES	Female	WHITE	HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2010	YES	NO	[Not Available]	[Not Available]	6	6	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	YES	22	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1183	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	44.42	1:Recurred/Progressed	13.60
48402D61-3A6B-4603-BFA0-B1A38A47D34D	TCGA-OR-A5JA	9/17/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	NO	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2004	YES	NO	[Not Available]	[Not Available]	9	90	Stage IV	R1	Imaging Suspected	[Not Available]	Lung|Liver|Other, specify	Androgen	Both Clinical and Biochemical Assessments	NO	NO	53	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	30.29	[Not Available]	[Not Available]
D63F2F1E-1970-445F-907B-23CF4D9EFD83	TCGA-OR-A5JB	9/17/13	NO	YES	Male	WHITE	[Not Available]	No	No	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2000	[Not Available]	[Not Available]	[Not Available]	[Not Available]	7	15	Stage IV	R1	Other, specify	excision of brain met	Other, specify	None	[Not Available]	NO	[Not Available]	52	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	18.1	[Not Available]	[Not Available]
BDFCD747-F6A2-42E2-BC9B-483112205FA8	TCGA-OR-A5JC	9/17/13	NO	YES	Male	WHITE	[Not Available]	No	No	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2001	[Not Available]	NO	[Not Available]	[Not Available]	8	24	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Estrogen	Biochemical Assessment	NO	[Not Available]	37	Atypical Mitotic Figures Present	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	57.49	[Not Available]	[Not Available]
240DCA72-76E0-4D57-978D-1242E6E7ED68	TCGA-OR-A5JD	9/17/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Left	Adrenocortical Carcinoma- Oncocytic Type	2005	[Not Available]	[Not Available]	[Not Available]	[Not Available]	3	4	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	[Not Available]	57	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2782	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	99.8	0:DiseaseFree	99.80
BAFE2638-4ADC-4957-9D62-D7EEBE5DD2F9	TCGA-OR-A5JE	9/17/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2005	[Not Available]	[Not Available]	[Not Available]	[Not Available]	8	60	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	NO	YES	17	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	69.15	1:Recurred/Progressed	15.67
DAFB9844-1A5C-4AF8-B382-59C751942BB8	TCGA-OR-A5JF	10/3/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2007	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	4	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	NO	[Not Available]	69	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1259	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	66.2	0:DiseaseFree	66.20
71892706-F8B6-44E6-8DE4-6CBB43F612E0	TCGA-OR-A5JG	10/3/13	NO	YES	Male	WHITE	[Not Available]	No	No	WITH TUMOR	[Not Available]	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2008	YES	YES	8	6	9	100	Stage IV	R1	[Not Available]	[Not Available]	Other, specify	Cortisol	Both Clinical and Biochemical Assessments	NO	[Not Available]	61	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	17.77	[Not Available]	[Not Available]
4F845FEA-E823-47D6-89FB-36EE478A43B8	TCGA-OR-A5JH	2/6/14	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical Carcinoma- Oncocytic Type	2008	YES	[Not Available]	[Not Available]	[Not Available]	4	1	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	[Not Available]	32	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1227	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	69.32	0:DiseaseFree	69.32
B7ADB786-1F81-43CA-AC72-7243966CD439	TCGA-OR-A5JI	9/18/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2008	YES	NO	[Not Available]	[Not Available]	3	1	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	22	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1424	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	76.58	0:DiseaseFree	76.58
9EC86C06-E7A9-4EA6-B36D-6F832909054B	TCGA-OR-A5JJ	10/3/13	NO	YES	Male	WHITE	[Not Available]	No	No	WITH TUMOR	NO	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2009	YES	YES	6	6	9	50	Stage IV	R2	[Not Available]	[Not Available]	Lung	None	[Not Available]	YES	[Not Available]	65	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	309	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	16.1	[Not Available]	[Not Available]
A477B55D-A591-482F-A554-D8EF7298C23D	TCGA-OR-A5JK	10/3/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2009	YES	[Not Available]	[Not Available]	[Not Available]	8	4	Stage IV	R2	Biopsy Proven	[Not Available]	Lung	None	[Not Available]	NO	NO	49	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1255	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	49.18	0:DiseaseFree	49.18
0ACC28BC-D348-41DF-8F49-BC0332EB9BE4	TCGA-OR-A5JL	9/18/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2009	YES	NO	[Not Available]	[Not Available]	5	6	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	NO	NO	36	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	670	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	67.54	0:DiseaseFree	67.54
FB54458D-C373-46C2-841E-82663E13EFAA	TCGA-OR-A5JM	10/3/13	NO	YES	Female	WHITE	[Not Available]	No	Yes	WITH TUMOR	YES	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Biochemical Evidence of Disease	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2011	YES	[Not Available]	[Not Available]	[Not Available]	9	90	Stage IV	R1	Other, specify	[Not Available]	Liver	Cortisol	Both Clinical and Biochemical Assessments	NO	YES	25	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	18.46	1:Recurred/Progressed	2.37
4FBBBE43-3C0E-4475-BCF8-3745BD7195EB	TCGA-OR-A5JO	9/18/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2005	YES	NO	[Not Available]	[Not Available]	3	2	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	26	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	889	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	39.22	0:DiseaseFree	39.22
0B73CBBA-5520-4610-B649-912D76114033	TCGA-OR-A5JP	4/2/14	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2012	YES	NO	[Not Available]	[Not Available]	6	13	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	40	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	149	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	15.24	0:DiseaseFree	15.24
199560CB-15E5-4276-865A-7D44D47C856C	TCGA-OR-A5JQ	9/18/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical Carcinoma- Myxoid Type	2006	YES	NO	[Not Available]	[Not Available]	4	3	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	26	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	674	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	36.24	0:DiseaseFree	36.24
A19104D6-B6A6-4878-AF2C-783679070A05	TCGA-OR-A5JR	9/9/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2002	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	YES	NO	45	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	3688	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	121.16	0:DiseaseFree	121.16
82940E94-AC74-4A9B-9DA5-9E4B7D4D45C0	TCGA-OR-A5JS	9/9/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	[Not Available]	35	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	YES	65	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	383	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	12.58	1:Recurred/Progressed	5.45
C0E1A036-BE4C-4FB5-BB50-E2431BE60ED4	TCGA-OR-A5JT	9/9/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	YES	YES	YES	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	17	0	[Not Available]	5	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	YES	NO	65	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	488	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	29.8	0:DiseaseFree	29.80
CAC8EABA-9E40-4048-B8CC-87574F048D91	TCGA-OR-A5JU	2/6/14	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	YES	YES	YES	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2010	YES	NO	[Not Available]	[Not Available]	[Not Available]	10	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	YES	YES	58	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	[Not Available]	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	9.49	1:Recurred/Progressed	8.80
388B8788-A635-4BC9-9B73-D204B2256747	TCGA-OR-A5JV	9/9/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2008	YES	YES	1	0	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	YES	55	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1541	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	[Not Available]	Necrosis Absent	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	66.46	1:Recurred/Progressed	31.31
63B7B596-CB55-41DC-B862-A6C3A058DFE2	TCGA-OR-A5JW	9/9/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2008	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	[Not Available]	NO	47	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1924	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	72.34	0:DiseaseFree	72.34
42F69B2B-F3AA-4F4E-AC3A-149E14789927	TCGA-OR-A5JX	9/10/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2009	YES	YES	1	0	[Not Available]	5	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	YES	NO	50	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	950	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	31.21	0:DiseaseFree	31.21
344F7EA4-2BD4-4F2D-89F2-9FC7F572A3D6	TCGA-OR-A5JY	9/10/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	YES	YES	NO	[Not Available]	[Not Available]	YES	NO	[Not Available]	Persistent distant metastases	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2011	YES	YES	2	1	[Not Available]	60	Stage IV	R2	Other, specify	surgical resection	Liver	Androgen|Cortisol	Both Clinical and Biochemical Assessments	[Not Available]	YES	68	[Not Available]	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N1	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	18.13	1:Recurred/Progressed	3.65
94CDAC79-2B4E-483A-8F17-3E0C9BE589D0	TCGA-OR-A5JZ	9/10/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	[Not Available]	5	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	YES	NO	60	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	211	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	27.0	1:Recurred/Progressed	8.11
EDC62C30-CACC-457D-96BA-D05ED35432A3	TCGA-OR-A5K0	9/16/13	NO	YES	Female	WHITE	[Not Available]	Yes	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2009	YES	NO	[Not Available]	[Not Available]	[Not Available]	8	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	[Not Available]	YES	69	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1029	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	33.8	1:Recurred/Progressed	21.65
F8E77BB6-E521-4A6A-9CB4-4B58EE38CA7F	TCGA-OR-A5K1	9/10/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2006	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	RX	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	YES	48	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	2723	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	108.05	1:Recurred/Progressed	27.14
6D980941-219E-40A0-9B41-E84C3FB0BD1A	TCGA-OR-A5K2	9/10/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	YES	YES	YES	YES	NO	YES	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2010	YES	YES	1	0	[Not Available]	51	Stage III	R0	Imaging Suspected	[Not Available]	Lung	Androgen|Cortisol	Both Clinical and Biochemical Assessments	YES	YES	32	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	32.65	1:Recurred/Progressed	3.19
C72B973B-4719-46AB-AC99-05D14088D3BC	TCGA-OR-A5K3	9/11/13	NO	YES	Male	WHITE	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical Carcinoma- Oncocytic Type	2005	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	53	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	2842	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	[Not Available]	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	113.83	0:DiseaseFree	113.83
70F1569E-F8F5-4F1D-BF18-D0586B29077D	TCGA-OR-A5K4	9/11/13	NO	YES	Female	WHITE	[Not Available]	No	No	TUMOR FREE	YES	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	[Not Available]	2	Stage III	R1	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	YES	NO	64	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	528	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	[Not Available]	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	35.55	0:DiseaseFree	35.55
CF332DAA-F335-4AF1-81DE-CBFDAFB0F764	TCGA-OR-A5K5	9/11/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	YES	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2012	YES	YES	20	0	[Not Available]	31	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	YES	YES	59	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	253	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	16.36	1:Recurred/Progressed	3.55
28153E3E-8515-4852-AAA0-247F86399F27	TCGA-OR-A5K6	10/8/13	YES	NO	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	YES	YES	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2010	YES	NO	[Not Available]	[Not Available]	5	7	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	[Not Available]	YES	56	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1130	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	49.05	1:Recurred/Progressed	12.84
1AE9CD13-73EF-4B1A-A734-4C465C73BC8E	TCGA-OR-A5K8	10/8/13	YES	NO	Male	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	NO	[Not Available]	NO	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2012	YES	NO	[Not Available]	[Not Available]	4	7	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	NO	NO	39	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	504	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	24.61	0:DiseaseFree	24.61
D890CBF7-41D8-4992-99C2-24C60C77B156	TCGA-OR-A5K9	9/11/13	NO	YES	Female	WHITE	[Not Available]	No	No	WITH TUMOR	NO	NO	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2002	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	[Not Available]	YES	61	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	1:DECEASED	11.3	1:Recurred/Progressed	7.75
09454ED6-64BC-4A35-AF44-7C4344623D45	TCGA-OR-A5KB	5/8/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	3	0	7	129	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	YES	61	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	741	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	24.34	1:Recurred/Progressed	7.03
B4B41A43-EE45-4AA3-ABF0-100DB752A6AC	TCGA-OR-A5KO	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2009	YES	[Not Available]	[Not Available]	[Not Available]	9	[Not Available]	Stage IV	R0	Biopsy Proven|Imaging Suspected	[Not Available]	Liver	Cortisol	Both Clinical and Biochemical Assessments	NO	NO	39	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1414	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	46.45	1:Recurred/Progressed	17.77
653F1D34-73E9-4216-B40B-E25C1CFC7943	TCGA-OR-A5KP	6/27/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	NO	YES	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2006	YES	YES	2	0	6	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	45	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2549	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	91.23	1:Recurred/Progressed	41.06
A3383252-1161-4B65-8BAC-125A6EDA3D08	TCGA-OR-A5KQ	6/26/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2006	YES	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Mineralocorticoids	Both Clinical and Biochemical Assessments	NO	NO	20	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2251	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	87.94	0:DiseaseFree	87.94
11D8A9C2-14D8-4FC2-8388-386051E408B1	TCGA-OR-A5KS	6/26/14	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2006	YES	NO	[Not Available]	[Not Available]	[Not Available]	0	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	72	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	2549	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/1	C74.0	YES	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	83.74	0:DiseaseFree	83.74
DE7F06AA-9638-4389-AC8E-711ADFA0F2A5	TCGA-OR-A5KT	4/2/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2006	YES	[Not Available]	[Not Available]	[Not Available]	2	1	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	44	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2673	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	95.11	1:Recurred/Progressed	68.96
424A497A-48B9-4507-B234-C4FD08C8ACAD	TCGA-OR-A5KU	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	[Not Available]	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2000	YES	YES	1	0	2	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	NO	NO	37	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	4673	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/1	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	153.52	0:DiseaseFree	153.52
202F7A77-9E5A-4F12-8FFE-78AE5527A746	TCGA-OR-A5KV	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	YES	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2003	YES	YES	1	1	3	[Not Available]	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Biochemical Assessment	NO	YES	17	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	3659	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	127.4	1:Recurred/Progressed	36.66
69F4F19C-08C8-4001-92A8-FED155C3B4FE	TCGA-OR-A5KW	11/7/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2009	YES	YES	9	8	[Not Available]	10	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	NO	55	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1525	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	N1	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	68.2	0:DiseaseFree	68.20
33C02ECE-911B-4F45-B410-9DF07E9B189E	TCGA-OR-A5KX	11/6/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2010	YES	YES	[Not Available]	[Not Available]	7	[Not Available]	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	YES	25	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1091	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	44.81	1:Recurred/Progressed	2.04
5F461197-15ED-43CF-9331-9E0EFC4622A4	TCGA-OR-A5KY	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	NO	[Not Available]	[Not Available]	YES	YES	NO	Persistent distant metastases	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2010	YES	YES	52	52	3	5	Stage IV	R2	Imaging Suspected	[Not Available]	Bone|Lung|Peritoneum	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	23	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N1	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	12.84	1:Recurred/Progressed	6.01
99F86B57-3894-45C5-BFBE-C757C69A3050	TCGA-OR-A5KZ	11/7/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent locoregional disease	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2012	YES	[Not Available]	[Not Available]	[Not Available]	8	[Not Available]	Stage II	RX	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	NO	YES	42	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	4.11	1:Recurred/Progressed	1.18
3ED33021-8EFD-420F-9A0B-E7420B586BCD	TCGA-OR-A5L1	6/27/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2000	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Biochemical Assessment	NO	YES	37	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1781	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	58.51	1:Recurred/Progressed	22.50
A26B6F97-FD7E-4B96-BDF5-9DF4F9233726	TCGA-OR-A5L2	6/26/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2001	YES	NO	[Not Available]	[Not Available]	[Not Available]	30	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	NO	83	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/1	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	1:DECEASED	60.84	[Not Available]	[Not Available]
A9A57127-94D3-425F-A4C5-5CBCF24A9A35	TCGA-OR-A5L3	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2000	YES	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	Cortisol	Both Clinical and Biochemical Assessments	NO	NO	67	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	3897	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	152.04	0:DiseaseFree	152.04
905368C2-BA60-4DDA-B32D-A51A203B5E4D	TCGA-OR-A5L4	4/2/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Applicable]	Right	Adrenocortical carcinoma- Usual Type	2011	YES	[Not Available]	[Not Available]	[Not Available]	7	[Not Available]	Stage III	RX	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	NO	48	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	724	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	31.77	0:DiseaseFree	31.77
2F04E760-8A64-49F2-A1D6-3D390604745C	TCGA-OR-A5L5	11/6/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	Yes	No	TUMOR FREE	NO	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2010	YES	NO	[Not Available]	[Not Available]	4	15	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Estrogen	Biochemical Assessment	NO	NO	77	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	840	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	43.27	0:DiseaseFree	43.27
F13A3D5E-7F8E-4ACB-AD46-F6380A9443E8	TCGA-OR-A5L6	11/5/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2011	YES	[Not Available]	[Not Available]	[Not Available]	7	23	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen	Biochemical Assessment	NO	NO	60	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	628	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	28.29	0:DiseaseFree	28.29
5E086192-AB74-4AA3-BF6B-B34AB19995DB	TCGA-OR-A5L8	11/4/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Applicable]	Right	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	4	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Mineralocorticoids|Cortisol	Both Clinical and Biochemical Assessments	NO	NO	36	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	555	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	29.07	0:DiseaseFree	29.07
C6312DE5-DD56-4025-80D1-DBDD8568D047	TCGA-OR-A5L9	11/4/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Applicable]	Right	Adrenocortical carcinoma- Usual Type	2011	YES	YES	5	0	3	5	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	NO	NO	53	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	645	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/1	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	28.61	0:DiseaseFree	28.61
E93CA89F-CA48-43CA-BF1C-ADC7491C0FE5	TCGA-OR-A5LA	11/6/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2012	YES	NO	[Not Available]	[Not Available]	5	1	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	52	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	487	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	23.62	0:DiseaseFree	23.62
FB504E55-1859-48EE-AEC7-A3FCB082785E	TCGA-OR-A5LB	11/4/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	Yes	No	WITH TUMOR	YES	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	YES	YES	No imaging evidence of disease	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	2006	YES	NO	[Not Available]	[Not Available]	4	8	Stage IV	R0	Other, specify	Operation	Liver|Other, specify	Androgen	Biochemical Assessment	NO	YES	59	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	39.55	1:Recurred/Progressed	20.07
F8954241-E541-406F-A09D-C3C987473732	TCGA-OR-A5LC	11/4/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	YES	NO	[Not Available]	Persistent distant metastases	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2011	YES	[Not Available]	[Not Available]	[Not Available]	3	[Not Available]	Stage IV	R2	Biopsy Proven|Imaging Suspected	[Not Available]	Bone|Liver	Cortisol	Both Clinical and Biochemical Assessments	NO	YES	71	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	5.22	1:Recurred/Progressed	1.64
D885B720-E813-4828-A731-B3CDCBD20687	TCGA-OR-A5LD	11/7/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	1998	YES	NO	[Not Available]	[Not Available]	5	[Not Available]	Stage III	RX	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	YES	52	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	39.32	1:Recurred/Progressed	14.59
C4DD9501-C193-45FB-8535-A9D901520BDD	TCGA-OR-A5LE	11/4/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	1997	YES	YES	[Not Available]	[Not Available]	5	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	YES	14	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	21.75	1:Recurred/Progressed	8.71
7E61E3B8-C617-4A5F-AFDF-689521C9A670	TCGA-OR-A5LF	6/27/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2002	YES	NO	[Not Available]	[Not Available]	5	[Not Available]	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	74	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	14.62	[Not Available]	[Not Available]
FAD4B7E6-510C-4968-83DF-3140ED5A0549	TCGA-OR-A5LG	11/5/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2008	YES	YES	1	0	6	[Not Available]	Stage III	RX	[Not Available]	[Not Available]	Liver	Cortisol	Both Clinical and Biochemical Assessments	NO	YES	46	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1589	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	52.2	1:Recurred/Progressed	45.76
CF327482-199B-4604-AC19-C8B68D91C5D9	TCGA-OR-A5LH	11/5/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2005	YES	NO	[Not Available]	[Not Available]	3	5	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	NO	NO	36	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	78.35	[Not Available]	[Not Available]
EC9C3EFE-AF61-4DEB-B047-DCF7EE735FD2	TCGA-OR-A5LI	6/26/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Right	Adrenocortical carcinoma- Usual Type	1998	YES	NO	[Not Available]	[Not Available]	6	[Not Available]	Stage IV	R2	Imaging Suspected	[Not Available]	Lung	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	42	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	14.32	1:Recurred/Progressed	2.00
FC83AB27-929E-4AD4-BA18-ABB0694F1E43	TCGA-OR-A5LJ	11/7/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	YES	[Not Available]	[Not Available]	Persistent distant metastases	Progressive Disease	Left	Adrenocortical carcinoma- Usual Type	2005	YES	YES	[Not Available]	[Not Available]	8	10	Stage IV	R2	Imaging Suspected	[Not Available]	Lung|Other, specify	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	54	Atypical Mitotic Figures Present	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N1	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	36.3	1:Recurred/Progressed	3.22
9C87DCEE-D422-4DF1-82E1-3FA201473E31	TCGA-OR-A5LK	11/27/13	NO	YES	Male	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical Carcinoma- Oncocytic Type	2007	YES	NO	[Not Available]	[Not Available]	5	7	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	62	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	2222	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	90.01	0:DiseaseFree	90.01
0304B12D-7640-4150-A581-2EEA2B1F2AD5	TCGA-OR-A5LL	11/27/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	WITH TUMOR	NO	YES	YES	YES	YES	YES	NO	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2007	YES	YES	10	0	7	15	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	75	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	52.99	1:Recurred/Progressed	7.00
E612EF6E-F3F2-44BE-AB15-8E4095687CD6	TCGA-OR-A5LM	11/27/13	NO	YES	Male	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2008	YES	YES	32	0	7	18	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Estrogen	Both Clinical and Biochemical Assessments	NO	NO	23	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1858	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	61.04	0:DiseaseFree	61.04
56CDBBA2-327E-4ACD-A1EB-0F313A77834F	TCGA-OR-A5LN	11/27/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2008	YES	YES	10	0	6	6	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	31	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1916	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	76.94	0:DiseaseFree	76.94
1D5602A7-72E7-4DC6-B2DB-2F778FCBF475	TCGA-OR-A5LO	11/27/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	WITH TUMOR	NO	YES	YES	YES	YES	YES	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2008	YES	YES	19	0	7	12	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Estrogen	Both Clinical and Biochemical Assessments	NO	YES	61	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1949	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	79.01	1:Recurred/Progressed	5.03
DFEF51C8-6050-4EBB-B25C-E74919397244	TCGA-OR-A5LP	11/27/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2009	YES	YES	21	0	5	0	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	37	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	1583	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	61.01	0:DiseaseFree	61.01
723EB689-7B4F-4758-BCDF-426B12508935	TCGA-OR-A5LR	11/26/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	NO	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	7	6	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Mineralocorticoids	Both Clinical and Biochemical Assessments	NO	NO	30	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	639	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	28.02	0:DiseaseFree	28.02
F63946EC-DDCB-469A-8F5E-74366B7F419B	TCGA-OR-A5LS	11/27/13	NO	YES	Female	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2011	YES	NO	[Not Available]	[Not Available]	6	7	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	NO	34	Atypical Mitotic Figures Absent	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	882	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	36.01	0:DiseaseFree	36.01
15FB07AE-101C-4553-891D-539CEE89A5E9	TCGA-OR-A5LT	11/27/13	NO	YES	Male	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	YES	YES	YES	YES	NO	[Not Applicable]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2012	YES	YES	18	0	8	10	Stage III	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	NO	NO	57	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	365	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T3	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OR	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	18.04	0:DiseaseFree	18.04
A5BE4E42-CB6C-4E67-8547-45DBD058BB95	TCGA-OU-A5PI	7/16/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	YES	YES	YES	[Not Available]	[Not Available]	NO	[Not Available]	[Not Available]	Persistent distant metastases	Stable Disease	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	3	3	2	[Not Available]	Stage IV	[Not Available]	Other, specify	Resection	Lung	None	[Not Available]	YES	YES	53	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Absent	0	709	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Absent	[Not Applicable]	N1	T2	[Not Available]	RET Negative	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	OU	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	38.47	1:Recurred/Progressed	11.53
888A7158-2319-4563-849B-573705C72AB7	TCGA-P6-A5OF	8/15/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2010	YES	NO	[Not Available]	[Not Available]	4	[Not Available]	Stage III	RX	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	NO	YES	55	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	P6	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	1:DECEASED	6.8	1:Recurred/Progressed	4.70
0824B246-9FA2-4A8B-AD4C-1FFC7731BF7D	TCGA-P6-A5OG	8/15/13	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	Yes	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Persistent distant metastases	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	6	0	4	[Not Available]	Stage IV	R2	Biopsy Proven	[Not Available]	Liver	Cortisol	Biochemical Assessment	NO	YES	45	Atypical Mitotic Figures Absent	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Absent	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Absent	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	P6	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	1:DECEASED	12.58	1:Recurred/Progressed	0.36
92B67CA9-6C82-463E-9CC5-685A1D02EA3E	TCGA-P6-A5OH	3/25/14	NO	YES	Female	WHITE	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2010	[Not Available]	[Not Available]	[Not Available]	[Not Available]	4	[Not Available]	Stage IV	R2	Biopsy Proven	[Not Available]	Liver	[Not Available]	[Not Available]	NO	NO	59	[Not Available]	M1	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	[Not Available]	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	P6	[Not Available]	Adrenal	[Not Available]	[Not Available]	1:DECEASED	0.0	[Not Available]	[Not Available]
8B3649E3-16E2-4044-8AB8-F4D28A87E513	TCGA-PA-A5YG	4/7/14	YES	NO	Male	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	Complete Remission/Response	Left	Adrenocortical carcinoma- Usual Type	2012	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	NO	51	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	470	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	PA	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	24.84	0:DiseaseFree	24.84
42EF34CC-FFB4-432C-82BB-7AA56639FF51	TCGA-PK-A5H8	9/16/13	NO	YES	Male	WHITE	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2004	YES	NO	[Not Available]	[Not Available]	7	9	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	42	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	3240	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	PK	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	119.02	0:DiseaseFree	119.02
83E7B9F8-04A4-440F-AAFC-7A8E9DDFF284	TCGA-PK-A5H9	9/16/13	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	No	No	TUMOR FREE	NO	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Right	Adrenocortical carcinoma- Usual Type	2012	YES	NO	[Not Available]	[Not Available]	4	2	Stage II	R0	[Not Available]	[Not Available]	[Not Available]	Androgen	Both Clinical and Biochemical Assessments	YES	NO	27	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	307	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Absent	Mitotic Rate > 5/50 HPF Absent	Necrosis Absent	Nuclear Grade III or IV Absent	[Not Applicable]	N0	T2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Absent	[Not Available]	[Not Applicable]	PK	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	20.24	0:DiseaseFree	20.24
5EB5EE1F-ECFF-4427-B717-B91380C043AE	TCGA-PK-A5HA	9/16/13	NO	YES	Male	[Not Available]	[Not Available]	No	No	TUMOR FREE	NO	NO	NO	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	No imaging evidence of disease	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2011	YES	YES	1	0	8	[Not Available]	Stage I	R0	[Not Available]	[Not Available]	[Not Available]	None	[Not Available]	[Not Available]	NO	63	Atypical Mitotic Figures Present	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	830	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T1	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	PK	[Not Available]	Adrenal	[Not Available]	Venous Invasion Absent	0:LIVING	39.45	0:DiseaseFree	39.45
9A8EA017-0152-48B2-ACCB-D040DEB1C6B6	TCGA-PK-A5HB	9/16/13	NO	YES	Male	[Not Available]	[Not Available]	Yes	No	WITH TUMOR	YES	YES	NO	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Left	Adrenocortical carcinoma- Usual Type	2003	[Not Available]	YES	2	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	YES	63	[Not Available]	[Not Available]	[Not Applicable]	[Not Applicable]	[Not Applicable]	[Not Available]	0	1293	[Not Available]	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	PK	[Not Available]	Adrenal	[Not Available]	[Not Available]	0:LIVING	42.48	1:Recurred/Progressed	7.00
891B7A67-0A01-45F0-8A32-4A1B3E888F6C	TCGA-PK-A5HC	3/13/14	NO	YES	Female	ASIAN	NOT HISPANIC OR LATINO	No	No	WITH TUMOR	NO	NO	YES	NO	[Not Available]	[Not Available]	[Not Available]	YES	YES	No imaging evidence of disease	Complete Remission/Response	Right	Adrenocortical carcinoma- Usual Type	2011	YES	YES	3	0	[Discrepancy]	19	Stage III	R1	[Not Available]	[Not Available]	[Not Available]	Androgen|Cortisol	Both Clinical and Biochemical Assessments	[Not Available]	YES	44	[Not Available]	M0	[Not Applicable]	[Not Applicable]	[Not Applicable]	Cytoplasm presence <= 25% Present	0	679	Diffuse Architecture Present	[Not Available]	[Not Applicable]	C74.0	8370/3	C74.0	YES	Invasion of Tumor Capsule Present	Mitotic Rate > 5/50 HPF Present	Necrosis Present	Nuclear Grade III or IV Present	[Not Applicable]	N0	T4	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	Sinusoid Invasion Present	[Not Available]	[Not Applicable]	PK	[Not Available]	Adrenal	[Not Available]	Venous Invasion Present	0:LIVING	22.31	1:Recurred/Progressed	5.49
